Isoform selective phospholipase D inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9127005
APP PUB NO 20120214832A1
SERIAL NO

13386397

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are isoform selective Phospholipase D inhibitors. In one aspect, the disclosed compounds can have a structure represented by a formula (I): Also disclosed are methods of making and using the compounds. Also disclosed are pharmaceutical compositions and kits comprising the compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VANDERBILT UNIVERSITY305 KIRKLAND HALL 2201 WEST END AVENUE NASHVILLE TN 37240

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, H Alex Franklin, US 6 1
Lindsley, Craig W Brentwood, US 203 1012
Scott, Sarah A Nashville, US 3 3
Waterson, Alex G Murfreesboro, US 14 47

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 8, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00